The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Estrogen receptor beta--a new dimension in estrogen mechanism of action
Abstract
The cloning of estrogen receptor (ER ) has provided the first example of a steroid hormone receptor existing as two isoforms, each of which is encoded by a separate gene (Kuiper et al. 1996). The finding of ER was met with great surprise, as the existence of more than one estrogen receptor had been actively denied for several decades. Attempts to clone a second estrogen receptor on the basis of sequence homology to the classical estrogen receptor (ER ) were not successful, although this approach did lead to the identification of two orphan receptors, namely estrogen receptor-related receptors (ERR) 1 and 2 (Giguere et al. 1988). However, none of these ER-related orphan receptors binds estrogens and it is still unclear whether they require specific ligands in order to be activated. ER seems to be a most important factor in the mechanism of action of estrogen, and it is expressed in many tissues, including the central nervous system, the cardiovascular system, the immune system, the urogenital tract, the gastrointestinal tract, the kidneys and the lungs (Arts et al. 1997, Enmark et al. 1997, Kuiper et al. 1997, 1998a, c, Lindner et al. 1998, O} sterlund et al. 1998). Although ER is also expressed in the mammary gland, it appears that ER is an important estrogen receptor in this particular tissue, and in the uterus also there seems to be much more ER present than ER (Fig. 1). This dominant role of ER in the uterus probably explains why it was the first cloned estrogen receptor, as most purification and cloning attempts were based on uterine tissue. As will be referred to below, it is now obvious that ER plays an important role in the physiology of several tissues, and it cannot be excluded that it is the more generally expressed estrogen receptor, whereas ER dominates in some few specific tissues and is mainly involved in reproductive events. Obviously, these differences in tissue distribution are of extreme importance from the pharmaceutical point of view, as hormone replacement therapy in postmenopausal women is such an increasingly significant health issue. Although the DNA-binding domains of ER and ER show a high degree of homology (only three amino acids differ), the ligand-binding domain shows only 59% homology (Fig. 2). Closer inspection indicates that it should be possible to develop ER and ER -specific ligands. In view of the facts presented above, it is not unreasonable to assume that it might be possible to develop ER -specific estrogen agonists targeting the central nervous system, the urogenital tract, the cardiovascular system and bone, but leaving the mammary gland and uterus relatively unaffected. In this way, much of the current controversy concerning estrogen treatment of postmenopausal women might be resolved (Barkhem et al. 1998, Gustafsson 1998a,b, Kuiper et al. 1998b, Nilsson et al. 1998).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kuiper, G. G. J. M., Carlsson, B., Grandien, K., Enmark, E., Häggblad, J., Nilsson, S., & Gustafsson, J.-A. (1997) · Endocrinology · doi:10.1210/endo.138.3.4979 · Cited by 4,442
Self-citationInteraction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β
Kuiper, G. G. J. M., Lemmen, J. G., Carlsson, B., Corton, J. C., Safe, S. H., van der Saag, P. T., van der Burg, B., & Gustafsson, J.-Å. (1998) · Endocrinology · doi:10.1210/endo.139.10.6216 · Cited by 4,203
Self-citationGeneration and reproductive phenotypes of mice lacking estrogen receptor β
Krege, J. H., Hodgin, J. B., Couse, J. F., Enmark, E., Warner, M., Mahler, J. F., Sar, M., Korach, K. S., Gustafsson, J.-Å., & Smithies, O. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15677 · Cited by 1,691
Self-citationIdentification of a new class of steroid hormone receptors
Giguère, V., Yang, N., Segui, P., & Evans, R. M. (1988) · Nature · doi:10.1038/331091a0 · Cited by 867
Barkhem, T., Carlsson, B., Nilsson, Y., Enmark, E., Gustafsson, J.-Å., & Nilsson, S. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.1.105 · Cited by 779
Self-citationEstrogen inhibits the vascular injury response in estrogen receptor α-deficient mice
Iafrati, M. D., Karas, R. H., Aronovitz, M., Kim, S., Sullivan, T. R., Lubahn, D. B., O'Donnell, T. F., Korach, K. S., & Mendelsohn, M. E. (1997) · Nature Medicine · doi:10.1038/nm0597-545 · Cited by 486
Österlund, M., G.J.M. Kuiper, G., Gustafsson, J.-Å., & Hurd, Y. L. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00351-3 · Cited by 379
Self-citationIncreased Expression of Estrogen Receptor-β mRNA in Male Blood Vessels After Vascular Injury
Lindner, V., Kim, S. K., Karas, R. H., Kuiper, G. G. J. M., Gustafsson, J.-A., & Mendelsohn, M. E. (1998) · Circulation Research · doi:10.1161/01.res.83.2.224 · Cited by 294
Self-citationSaunders, P., Fisher, J., Sharpe, R., & Millar, M. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.156r013 · Cited by 268
Hess, R. A., Gist, D. H., Bunick, D., Lubahn, D. B., Farrell, A., Bahr, J. M., Cooke, P. S., & Greene, G. L. (1997) · PubMed · Cited by 268
Mouse Estrogen Receptor Forms Estrogen Response Element-Binding Heterodimers with Estrogen Receptor
Pettersson, K. (1997) · Molecular Endocrinology · doi:10.1210/me.11.10.1486 · Cited by 203
Johansson, L., Thomsen, J. S., Damdimopoulos, A. E., Spyrou, G., Gustafsson, J.-Å., & Treuter, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.345 · Cited by 184
Self-citationInhibition of Estrogen Receptor Action by the Orphan Receptor SHP (Short Heterodimer Partner)
Seol, W., Hanstein, B., Brown, M. A., & Moore, D. D. (1998) · Molecular Endocrinology · doi:10.1210/mend.12.10.0184 · Cited by 146
Montano, M. M., Jaiswal, A. K., & Katzenellenbogen, B. S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.39.25443 · Cited by 141
Estrogen Receptor- mRNA Expression in Rat Ovary: Down-Regulation by Gonadotropins
Byers, M. (1997) · Molecular Endocrinology · doi:10.1210/me.11.2.172 · Cited by 114
Therapeutic potential of selective estrogen receptor modulators
Gustafsson, J.-Α. (1998) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(98)80127-0 · Cited by 105
Self-citationERβ a Novel Estrogen Receptor Offers the Potential for New Drug Development
Nilsson, S. V., Kuiper, G. G. J. M., & Gustafsson, J.-Α. (1998) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(98)00096-4 · Cited by 91
Self-citationRaloxifene: Magic bullet for heart and bone?
Gustafsson, J.-Α. (1998) · Nature Medicine · doi:10.1038/nm0298-152 · Cited by 26
Self-citation
Cited by
Selective Estrogen-Receptor Modulators — Mechanisms of Action and Application to Clinical Practice
Riggs, B. L., & Hartmann, L. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022219 · Cited by 968
Interaction of Phytoestrogens with Estrogen Receptors .ALPHA. and .BETA..
MORITO, K., HIROSE, T., KINJO, J., HIRAKAWA, T., OKAWA, M., NOHARA, T., OGAWA, S., INOUE, S., MURAMATSU, M., & MASAMUNE, Y. (2001) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.24.351 · Cited by 614
Estrogen Effects on Cognitive and Synaptic Health Over the Lifecourse
Hara, Y., Waters, E. M., McEwen, B. S., & Morrison, J. H. (2015) · Physiological Reviews · doi:10.1152/physrev.00036.2014 · Cited by 470
Interaction of Phytoestrogens with Estrogen Receptors .ALPHA. and .BETA.(II).
Morito, K., Aomori, T., Hirose, T., Kinjo, J., Hasegawa, J., Ogawa, S., Inoue, S., Muramatsu, M., & Masamune, Y. (2002) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.25.48 · Cited by 464
Liu, J., Burdette, J. E., Xu, H., Gu, C., van Breemen, R. B., Bhat, K. P. L., Booth, N., Constantinou, A. I., Pezzuto, J. M., Fong, H. H. S., et al. (2001) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0014157 · Cited by 428
Metadata
- Authors
- Gustafsson, J.
- Venue
- Journal of Endocrinology
- Publisher
- Bioscientifica
- Published
- 1999-12-01
- Volume
- 163
- Issue
- 3
- Pages
- 379-383
- ISSN
- 0022-0795 (ISSN-L)
- 1479-6805
- OpenAlex
- W2064482843
- Cited by
- 423
- References
- 18
- FWCI
- 14.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.